ProMIS Neurosciences Inc PMN

Another Biogen Ah ha moment

[retiredcop]

Not to be surprised with this news ...but interesting the weaker dose is still not limiting bleeding in brain ,  we now have even more to compare to when pmn310 starts in clinicals 


https://news.google.com/articles/CAIiELnkEGKuC_t_DDjVHYE0NrIqFQgEKg0IACoGCAow8oA-MLswMJKBAQ?hl=en-CA&gl=CA&ceid=CA%3Aen

[retiredcop]

https://news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FyaWEtc2lkZS1lZmZlY3RzLXN1cmZhY2UtNDAtcGF0aWVudHMtYmlvZ2VuLXMtYWx6aGVpbWVyLXMtZHJ1Zy1hZHVoZWxtLWphbWHSAQA?hl=en-CA&gl=CA&ceid=CA%3Aen

[retiredcop]

Sorry abou the google link .. this should work  https://newatlas.com/medical/brain-swelling-aduhelm-alzheimers-trial-side-effects/

[DavidKingCanada]

Biogen is the Ying we just need to find the Yang! 

[kalman007]

sorry dude, i agree with M101, it's time for them to put up or shut up. more dillution and soon our shares are totally worthless.   Clinicals were to begin for PMN310 years ago but they haven't.  Why?   The investment community is losing patience with these guy

[DavidKingCanada]

I think everyone is a bit ticked off at PMN, but other than asking for the CEO's head whatelse can we do?  I have no choice to wait because I sell now I will lose. Post Nasdaq the Price has to be around 5-6 to break even. I do believe the current SP will go up to low 20's before any sort of Consolidation. I will also sell at this Point.  But it does seem the we are in lose

[M101]

That wasn't my point, not this time anyway. My point was that mixed messaging comes with a credibility problem. It's tough to believe a company is interested in solving one of the great human afflictions while the company's leadership publicly idolizes the worst practises of big pharma.  Consider how an alternative promotional strategy could have progressed, one in which our

[M101]

So Adhuhelm has its first kill, unconfirmed but highly likely. Or as Elliot would say it's not best in class.  When will the leadership here realize it's past time to put some promotional distance between pmn310 and Aduhelm? 

[M101]

For anyone wondering why I occasionally flog this dead horse, try instead the question of why our consultants hitched us to a dead horse.   This stupid but easy promotional gimmick of mixed messaging is a big reason why Gene and Elliot failed to attract sufficient new investors.  Their qualified praise for Aducanumab as a useful stage to better drugs still prevents them from calling

[DavidKingCanada]

M101 no one really cares what you think. Your Post History is a Joke!